After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
MRUS belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Merus N.V is $2.99B. A total of 0.55 million shares were traded on the day, compared to an average of 686.60K shares.
In the most recent transaction, Shuman Harry sold 4,000 shares of MRUS for 48.50 per share on Mar 21 ’25. After the transaction, the VP Controller, PAO now owns 11,002 company shares. In a previous transaction on Aug 21 ’24, Shuman Harry sold 2,500 shares at 54.00 per share. MRUS shares that VP Controller, PAO owns now total 7,002.
Among the insiders who sold shares, Shuman Harry disposed of 2,500 shares on Aug 20 ’24 at a per-share price of $54.00. This resulted in the VP Controller, PAO holding 7,002 shares of MRUS after the transaction. In another insider transaction, Silverman Peter B. sold 10,000 shares at $60.00 per share on Jun 27 ’24. Company shares held by the COO & GC now total 0.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, MRUS has a high of $61.61 and a low of $33.19.
As of this writing, MRUS has an earnings estimate of -$1.05 per share for the current quarter. EPS was calculated based on a consensus of 11.0 estimates, with a high estimate of -$0.86 per share and a lower estimate of -$1.26.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. MRUS’s latest balance sheet shows that the firm has $410.43M in Cash & Short Term Investments as of fiscal 2021. There were $3.75M in debt and $71.90M in liabilities at the time. Its Book Value Per Share was $9.41, while its Total Shareholder’s Equity was $316.20M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MRUS is Buy with a score of 4.94.
